The European Parliament’s health committee is set to debate and vote on changes to the proposed pharmaceutical legislation on 19 March, including provisions that would increase market exclusivity and regulatory data protection compared to the European Commission’s proposal released last year.
Ahead of the debate, the Parliament’s Committee on Environment, Public Health and Food Safety (ENVI) has published compromise amendments to the European Commission’s proposed revisions to the existing directive its proposal for a new regulation. The amendments include suggested changes by the ENVI representatives leading the process and other members of the committee…
